Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Higher androgen levels are linked to more severe hair growth in hirsute women.

Early menarche may indicate higher risk of severe hirsutism in PCOS patients.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Birth control pills with cyproterone acetate and drosperinone can reduce excessive hair growth in women with PCOS, but they may not be right for everyone.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

Prolactin levels are higher in women with hirsutism but don't relate to its severity.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Adding a topical agent to IPL improves hair reduction and satisfaction without extra side effects.

The conclusion is that hirsutism in women can be managed with hair removal techniques, medications, and topical treatments.

Neem and Zanjabeel are as effective as standard drugs for treating hirsutism in PCOD patients.

Hirsutism is common among Iraqi women, often without a known cause, but family history is significant.